Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
What this bill does
Requiring a pharmacist, or the pharmacist's designee who is under certain supervision, to inform a consumer of the availability of a therapeutically equivalent brand name drug that is the lowest cost alternative to the originally prescribed drug or device and the cost difference between the equivalent drug or device and the prescribed drug; requiring a pharmacist to provide written notice, or to maintain a record that indicates a patient was notified in writing or orally, that the generic product is equivalent to the brand name product; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (10)
MGA witness list| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | locklair, caileylobbyist | Maryland Retailers Association | Oral |
| FAV | Koravos, JoAnne | Montgomery County Women's Democratic Club | Written (PDF) |
| FAV | Alsobrooks, Angela | Prince George's County Executive | Written (PDF) |
| FAV | Blair, David | Individual | Written (PDF) |
| FAV | Delegate Shetty, Delegate Shettylegislator | Individual | Oral |
| FAV | Peterson, Matt | Individual | Written (PDF) |
| FAV | Shetty, Emily | Individual | Written (PDF) |
| UNF | O'Connor, Patricia | Maryland Office of the Attorney General, Health Education and Advocacy Unit (HEAU) | Written (PDF) |
| FWA | Taylor, Allisonlobbyist | Kaiser Permanente | Oral + Written (PDF) |
| INFO | Bennardi, Maryland Department of Health /Office of Governmen | Maryland Dept. of Health | Written (PDF) |